協和キリンの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2015/10/27 | 1,964 | 1,987 | 1,943 | 1,953 | +10 | +0.5% | 1,274,000 |
| 2015/10/26 | 1,957 | 1,965 | 1,930 | 1,943 | +22 | +1.1% | 757,000 |
| 2015/10/23 | 1,953 | 1,959 | 1,915 | 1,921 | +7 | +0.4% | 1,798,000 |
| 2015/10/22 | 1,923 | 1,949 | 1,912 | 1,914 | -33 | -1.7% | 1,217,000 |
| 2015/10/21 | 1,931 | 1,956 | 1,894 | 1,947 | +16 | +0.8% | 1,425,000 |
| 2015/10/20 | 1,942 | 1,954 | 1,914 | 1,931 | +5 | +0.3% | 1,259,000 |
| 2015/10/19 | 1,890 | 1,972 | 1,885 | 1,926 | +27 | +1.4% | 2,062,000 |
| 2015/10/16 | 1,860 | 1,924 | 1,854 | 1,899 | +56 | +3% | 1,918,000 |
| 2015/10/15 | 1,782 | 1,852 | 1,773 | 1,843 | +96 | +5.5% | 2,081,000 |
| 2015/10/14 | 1,762 | 1,769 | 1,731 | 1,747 | -16 | -0.9% | 1,611,000 |
| 2015/10/13 | 1,724 | 1,770 | 1,724 | 1,763 | +48 | +2.8% | 1,645,000 |
| 2015/10/09 | 1,704 | 1,723 | 1,680 | 1,715 | +28 | +1.7% | 2,038,000 |
| 2015/10/08 | 1,748 | 1,748 | 1,683 | 1,687 | -75 | -4.3% | 1,697,000 |
| 2015/10/07 | 1,796 | 1,800 | 1,713 | 1,762 | -38 | -2.1% | 1,609,000 |
| 2015/10/06 | 1,801 | 1,805 | 1,777 | 1,800 | +1 | +0.1% | 1,319,000 |
| 2015/10/05 | 1,774 | 1,803 | 1,759 | 1,799 | +45 | +2.6% | 786,000 |
| 2015/10/02 | 1,755 | 1,770 | 1,740 | 1,754 | -6 | -0.3% | 754,000 |
| 2015/10/01 | 1,777 | 1,778 | 1,704 | 1,760 | -18 | -1% | 1,449,000 |
| 2015/09/30 | 1,730 | 1,797 | 1,724 | 1,778 | +128 | +7.8% | 2,203,000 |
| 2015/09/29 | 1,728 | 1,728 | 1,640 | 1,650 | -109 | -6.2% | 1,735,000 |
| 2015/09/28 | 1,785 | 1,802 | 1,735 | 1,759 | -13 | -0.7% | 1,338,000 |
| 2015/09/25 | 1,768 | 1,806 | 1,740 | 1,772 | +44 | +2.5% | 1,705,000 |
| 2015/09/24 | 1,778 | 1,787 | 1,728 | 1,728 | -83 | -4.6% | 2,375,000 |
| 2015/09/18 | 1,817 | 1,860 | 1,811 | 1,811 | -36 | -1.9% | 1,708,000 |
| 2015/09/17 | 1,870 | 1,870 | 1,825 | 1,847 | -17 | -0.9% | 1,133,000 |
| 2015/09/16 | 1,885 | 1,888 | 1,843 | 1,864 | -13 | -0.7% | 1,053,000 |
| 2015/09/15 | 1,886 | 1,914 | 1,854 | 1,877 | +8 | +0.4% | 1,434,000 |
| 2015/09/14 | 1,888 | 1,929 | 1,869 | 1,869 | -17 | -0.9% | 1,526,000 |
| 2015/09/11 | 1,835 | 1,904 | 1,830 | 1,886 | +11 | +0.6% | 3,459,000 |
| 2015/09/10 | 1,866 | 1,900 | 1,848 | 1,875 | -70 | -3.6% | 2,140,000 |
| 2015/09/09 | 1,872 | 1,945 | 1,830 | 1,945 | +132 | +7.3% | 2,437,000 |
| 2015/09/08 | 1,924 | 1,926 | 1,803 | 1,813 | -104 | -5.4% | 1,566,000 |
| 2015/09/07 | 1,905 | 1,939 | 1,873 | 1,917 | +9 | +0.5% | 924,000 |
| 2015/09/04 | 1,978 | 1,981 | 1,888 | 1,908 | -48 | -2.5% | 1,529,000 |
| 2015/09/03 | 2,006 | 2,037 | 1,950 | 1,956 | -33 | -1.7% | 1,713,000 |
| 2015/09/02 | 1,926 | 2,044 | 1,920 | 1,989 | +53 | +2.7% | 1,765,000 |
| 2015/09/01 | 2,014 | 2,033 | 1,934 | 1,936 | -103 | -5.1% | 1,276,000 |
| 2015/08/31 | 2,060 | 2,060 | 2,013 | 2,039 | -26 | -1.3% | 1,221,000 |
| 2015/08/28 | 2,056 | 2,068 | 2,025 | 2,065 | +53 | +2.6% | 1,382,000 |
| 2015/08/27 | 2,005 | 2,039 | 1,993 | 2,012 | +39 | +2% | 1,302,000 |
| 2015/08/26 | 1,909 | 1,986 | 1,909 | 1,973 | +64 | +3.4% | 1,937,000 |
| 2015/08/25 | 1,955 | 2,046 | 1,907 | 1,909 | -97 | -4.8% | 2,590,000 |
| 2015/08/24 | 2,080 | 2,105 | 2,004 | 2,006 | -107 | -5.1% | 1,596,000 |
| 2015/08/21 | 2,117 | 2,138 | 2,098 | 2,113 | -79 | -3.6% | 1,555,000 |
| 2015/08/20 | 2,201 | 2,248 | 2,188 | 2,192 | -20 | -0.9% | 1,048,000 |
| 2015/08/19 | 2,300 | 2,321 | 2,209 | 2,212 | -16 | -0.7% | 1,860,000 |
| 2015/08/18 | 2,250 | 2,281 | 2,217 | 2,228 | +25 | +1.1% | 1,673,000 |
| 2015/08/17 | 2,150 | 2,214 | 2,149 | 2,203 | +78 | +3.7% | 1,138,000 |
| 2015/08/14 | 2,138 | 2,155 | 2,110 | 2,125 | -27 | -1.3% | 1,762,000 |
| 2015/08/13 | 2,050 | 2,160 | 2,026 | 2,152 | +126 | +6.2% | 2,143,000 |
2401～
2450
件表示中 / 3768件
類似銘柄と比較する
現在ご覧いただいている「協和キリン」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 協和キリン | 263,900円 | -3.5% | -11.3% | 2.27% | 24.24倍 | 1.64倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
| アステラス薬 | 169,200円 | +0.9% | +380.2% | 4.61% | 23.31倍 | 2.00倍 |
|
医薬品国内２位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
| 塩野義 | 258,000円 | +20.9% | +10.6% | 2.56% | 12.20倍 | 1.61倍 |
|
抗ＨＩＶ薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
| エーザイ | 467,600円 | +0.1% | -3.4% | 3.42% | 31.79倍 | 1.57倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
| 小野薬 | 166,100円 | +0.6% | +43.3% | 4.82% | 11.65倍 | 1.00倍 |
|
医療用医薬品専業の中堅。自社開発品多い。先駆的がん免疫阻害剤「オプジーボ」が成長牽引 |
市場注目の銘柄
チャート関連のコラム
